Photofrin Lung Cancer Toxicity May Reflect Follow-Up Bias - Expanded Label
Executive Summary
The greater toxicity rate seen during Photofrin clinical trials in late lung cancer patients may be due to bias introduced by a longer follow-up period for Photofrin patients compared to those treated with Nd:YAG laser for endobronchial obstruction, product labeling notes.